Agilent Revenues Up 16 Percent in Q2, Swings to Profit
May 18, 2010
Agilent Revenues Up 16 Percent in Q2, Swings to Profit
The company said that the Varian purchase, completed last week, is expected to add $370 million in revenue for the second half of its fiscal-year 2010, 30 percent of which would go to Life Sciences.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.